Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in a 2-YearOld Child with Abdominopelvic Rhabdomyosarcoma: A Case Report of Anaesthetic Concerns.
Turk J Anaesthesiol Reanim
; 50(1): 68-71, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35256349
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a well-established multimodal treatment in patients with peritoneal surface malignancies in adults. Children younger than 3 years rarely undergo such extensive surgeries with heated chemotherapy infusion intraoperatively. Only one such case is reported in the literature for CRS-HIPEC for an abdominopelvic rhabdomyosarcoma in a child of 2 years or less. We present the case of a 2-year-old child with abdominopelvic rhabdomyosarcoma undergoing CRS-HIPEC and discuss the perioperative concerns and challenges.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Turk J Anaesthesiol Reanim
Year:
2022
Document type:
Article
Affiliation country:
India
Country of publication:
Turkey